CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- 4 Shares withheld for taxes CEO gave up 494 shares (to pay taxes)
- 4 Open-market buy Director bought 23,567 shares at $5.07 ($119,485)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO bought 145,000 shares at $0.35 ($50,663)
- 4 Open-market buy Director bought 300,000 shares at an average $0.35 ($105,040)
- 4 Shares withheld for taxes CEO gave up 22,405 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHINA OPERATIONS gave up 7,430 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,325 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 2,512 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 2,363 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHINA OPERATIONS gave up 2,792 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 17,115 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 2,363 shares (to pay taxes)
Page 2 of 38 · 759 filings